Valeant acquires iNova

Valeant Pharmaceuticals International, Inc. announced that effective December 21, 2011, the company completed its previously announced acquisition of iNova, from Archer Capital, Ironbridge and other minority management shareholders.

BofA Merrill Lynch and Baker & McKenzie acted as Valeant’s advisors in connection with this transaction.

Similar Posts:

• Texas-Based Insurer GAINSCO to Deregister Its Common Stock
• Former Calif. Deputy Insurance Commissioner Gary A. Hernandez Passes
• The Basics of Workers Compensation Medical Accreditation
• UK Broker BMS Continues Overall Growth
• Cyanotech third quarter revenues increase to $6,706,000

Tags: Inova   Posted in Insurance Quotes